enVVeno Medical Corp expected to post a loss of 40 cents a share - Earnings Preview

enVVeno Medical

04/05/2024 03:02

* enVVeno Medical Corp  NVNO.OQ   NVNO.O  is expected
to show no
change in quarterly revenue when it reports  results on May 6
(estimated) for the period ending March 31 2024
    * 
    * ​LSEG's mean analyst estimate for enVVeno Medical Corp is
for a
loss of 40 cents per share. 
    * The one available analyst rating on the shares is "strong
buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for enVVeno
Medical
Corp is $20.40​, above​ its last closing price of $5.05. ​​​

This summary was machine generated May 4 at 02:02 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)